Not recruiting
Cytomegalovirus immunisation
Not recruitingEfficacy, Safety, and Immunogenicity of mRNA-1647 Vaccine in Preventing Primary Cytomegalovirus Infection in CMV-Seronegative Females Aged 16-40
Registered drug
Efficacy, Safety, and Immunogenicity of mRNA-1647 Vaccine in Preventing Primary Cytomegalovirus Infection in CMV-Seronegative Females Aged 16-40
Registered drug
- Disease:Cytomegalovirus immunisation
- Substances:Sodium ChlorideMRNA encoding human cytomegalovirus glycoprotein B+5
Countries:
Belgium
Belgium- Participants:0–17 years · 18–64 years · Healthy volunteers
- Substances:Sodium Chloride
